Background: Both old age and institutionalization in aged care homes come with a
significant risk of developing several long-term mental and neurological disorders, but there …

Few recent studies have investigated the prevalence and outcomes for central nervous
system (CNS)-active medication use in older persons with dementia (PWD) who live in the …

Background: Neuropsychiatric symptoms of dementia are often treated through the
prescription of one or more psychotropic medications. However, limited efficacy and …

Background Most studies assessing the effect of central nervous system (CNS)-acting
medicines on cognitive disturbances have focused on the use of individual medicines. The …

Background: Antipsychotic medications are often used 'off-licence'to treat neuropsychiatric
symptoms and disorders of aging and to manage behavioural and psychological symptoms …

Background Psychotropic medications are commonly prescribed to people with dementia
(PwD) for non-cognitive symptoms of dementia (NCSD), but have significant risks. A national …

Background: To produce a practice guideline that includes a set of detailed consensus
principles regarding the prescription of antipsychotics (APs) amongst people with dementia …

Background The number of people with dementia is increasing alongside the aging
population, and most of these patients manifest with neuropsychiatric symptoms (NPS). The …

Background and Objectives: The global trend of healthcare is to improve the quality and
safety of care for older people with cognitive disorders in their own home. There is a need to …

Introduction: It is well established that there is a high prescribing rate of psychotropic agents
in residential aged care (RAC). The appropriateness of these medications has become …